Serpin B-5 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Serpin B-5 (Maspin; UniProt P36952), expressed in HEK293 cells. Suited for antibody validation, protein-binding studies, and cell-based functional assays in cancer and inflammatory disease research.
Expression system
HEK293
Cat. #
REC-SerpinB5

In stock

SKU
REC-SerpinB5
$498.00

Target Overview

Serpin B-5, commonly known as Maspin, is a 375-amino-acid member of the clade B (ovalbumin-type) serpin superfamily encoded by the SERPINB5 gene (UniProt P36952). Unlike most classical serpins, Maspin does not undergo the stressed-to-relaxed (S→R) conformational transition and therefore lacks canonical serine protease inhibitory activity. Its biological functions are instead attributed to direct protein–protein interactions and transcriptional regulatory roles, making it a structurally and functionally distinct serpin. This recombinant is produced in HEK293 mammalian cells, a system that supports the glycosylation and folding patterns relevant to human Serpin B-5 biology. Mammalian expression is particularly appropriate for this target because conformational integrity — rather than catalytic activity — underpins its interactions with binding partners such as desmoplakin and components of the TGF-β signalling axis. Researchers use this recombinant in several experimental contexts. As a positive control antigen, it is well-suited for validating anti-Maspin antibodies in Western blot and ELISA formats; it pairs directly with Triple Point Biologics' matched antibody (RP-SerpinB5), which has been validated for Western blot against human targets. In binding and co-immunoprecipitation experiments, the recombinant serves as bait or prey to map interaction partners. In cell-based assays examining invasion, adhesion, or epithelial integrity, exogenous Serpin B-5 can be applied to characterise dose-dependent effects on cell behaviour. The full-length 375-residue sequence also makes it suitable for generating or benchmarking ELISA standard curves in biomarker quantification studies. Investigators working on epithelial-to-mesenchymal transition (EMT), RNA modification biology, or skin barrier signalling have an appropriately folded, human-sourced protein for in vitro reconstitution experiments.

Background

Serpin B-5 (Maspin) was originally identified as a class II tumour suppressor in mammary epithelial cells and has since been characterised across a broad range of epithelial tissues. Despite sharing the serpin fold, Maspin lacks the reactive-centre loop mobility required for protease inhibition; its suppressive functions instead arise from modulating cell adhesion, invasion, and transcriptional programmes through direct protein interactions and subcellular localisation changes. In breast, prostate, and lung cancer research, Maspin expression is frequently downregulated during malignant progression, and its loss correlates with increased invasiveness and metastatic potential in published tumour models. More recently, the protein has been studied in the context of epithelial RNA modification biology. Liu et al. (2026) reported that m⁵C-driven stabilisation of SERPINB5 mRNA promotes cervical cancer progression and chemotherapy resistance, situating Maspin at the intersection of epitranscriptomic regulation and tumour cell survival (PMID 41673397). Separately, Pu et al. (2026) demonstrated that METTL3/YTHDF1-mediated m⁶A modification of SerpinB5 mRNA drives M1 macrophage polarisation and aggravates ulcerative colitis progression through an FBXO32-dependent NF-κB pathway (PMID 41485180), extending the research relevance of this target into inflammatory bowel disease models. Beyond cancer and inflammation, Serpin B-5 has been investigated in skin biology. Rathod et al. (2025) showed that SERPINB5/TGF-β signalling modulates desmoplakin membrane localisation and ameliorates skin blistering in pemphigus vulgaris models, identifying a direct functional link between Maspin and desmoglein-dependent epidermal adhesion structures (PMID 41037786). This finding highlights the utility of a well-folded recombinant for reconstituting signalling interactions in keratinocyte and skin explant systems. Taken together, published research positions Serpin B-5 as a research target relevant to tumour biology, RNA epigenetics, macrophage-mediated inflammation, and epithelial barrier integrity — spanning a range of in vitro and ex vivo experimental models. The HEK293-expressed recombinant provides a conformationally relevant, human-sequence protein for these applications. Researchers requiring an orthogonal detection reagent can pair this recombinant with the Triple Point Biologics anti-Serpin B-5 antibody (RP-SerpinB5), validated for Western blot against human targets — a combination that Triple Point has supported across its proteinase/inhibitor antibody portfolio since 1994.

Applications

  • Antibody validation positive control in Western blot (pairs with matched TPB antibody RP-SerpinB5)
  • ELISA standard curve generation and calibration for Maspin quantification in conditioned media or tissue lysates
  • Protein–protein interaction studies (co-IP, pull-down) to map Serpin B-5 binding partners including desmoplakin and TGF-β pathway components
  • Cell invasion and adhesion assays using exogenous recombinant Maspin to assess dose-dependent effects on epithelial cell behaviour
  • Epitranscriptomic pathway reconstitution experiments examining m⁵C/m⁶A-regulated SERPINB5 expression outcomes
  • NF-κB signalling assays in macrophage polarisation models requiring defined recombinant Maspin concentrations
  • IHC antigen control preparation for validating Maspin detection in tissue sections

References

  1. Liu J et al. M(5)C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance. Cell Death Dis. 2026. doi: 10.1038/s41419-026-08453-2. PMID: 41673397.
  2. Pu T et al. METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway. J Gastroenterol. 2026. doi: 10.1007/s00535-025-02341-w. PMID: 41485180.
  3. Rathod M et al. SERPINB5/TGF-β signaling modulates desmoplakin membrane localization and ameliorates pemphigus vulgaris skin blistering. JCI Insight. 2025. doi: 10.1172/jci.insight.183024. PMID: 41037786.
  4. Ozbek Sebin S et al. Emerging roles of vaspin and myonectin as novel biomarkers in prostate cancer diagnosis and staging. Urol Oncol. 2026. doi: 10.1016/j.urolonc.2025.10.024. PMID: 41253656.
  5. Webb BCW et al. Engineering a multilayered micro-vascularized soft tissue graft: Integrating polyurethane composite nanofibres with co-cultures of human adipose-derived endothelial and stem cells. Biomaterials. 2026. doi: 10.1016/j.biomaterials.2026.124064. PMID: 41702229.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; blood plasma

Frequently Asked Questions

What molecular weight band does recombinant Serpin B-5 / Maspin run at on SDS-PAGE or Western blot?

The predicted molecular weight of full-length Serpin B-5 (375 aa, UniProt P36952) is approximately 42 kDa. Under denaturing SDS-PAGE conditions, our HEK293-expressed recombinant typically migrates at 45–48 kDa — slightly above the theoretical mass due to post-translational modifications supported by the mammalian expression system. On Western blot using the matched antibody (RP-SerpinB5), expect a clean band in the 45–50 kDa range. Anomalous migration by a few kDa is normal and consistent with published endogenous Maspin reports in MCF-7 and LNCaP lysates.

Does recombinant Maspin / Serpin B-5 have serine protease inhibitory activity — can I use it in a protease inhibition assay?

No. Serpin B-5 (Maspin) is a non-inhibitory serpin: it does not undergo the stressed-to-relaxed (S→R) conformational transition required for canonical serine protease inhibition and does not form a covalent acyl-enzyme intermediate with targets such as trypsin, plasmin, or uPA. Do not use this recombinant in standard protease inhibition or IC50 assays expecting reactive centre loop (RCL)-mediated trapping. Its biological activity is attributed to protein–protein interactions (e.g., desmoplakin, TGF-β pathway components) and transcriptional regulatory roles — assay design should reflect those mechanisms.

What assays are appropriate for recombinant Serpin B-5 if it has no protease inhibitory activity?

Validated uses for this recombinant include: (1) protein–protein interaction studies — SPR, co-IP, or pull-down assays probing Maspin's binding to desmoplakin or TGF-β signalling components; (2) Western blot positive control at 50–200 ng per lane using the matched antibody RP-SerpinB5; (3) ELISA standard curve generation for quantifying endogenous Maspin in tissue lysates or conditioned media; and (4) cell-based uptake or localisation experiments where exogenously supplied recombinant protein is tracked. A starting concentration of 1–10 µg/mL is a reasonable working range for most binding assays; titrate to your specific system.

What buffer is recombinant Serpin B-5 supplied in and is it compatible with my binding assay?

REC-SerpinB5 is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol. This formulation maintains conformational integrity during storage. For SPR or ITC, dialyse or buffer-exchange into your running buffer (e.g., PBS pH 7.4 or HEPES-buffered saline) to avoid refractive index artifacts from glycerol. For co-IP or pull-down, the supplied buffer is generally compatible — simply dilute ≥5-fold into your lysis/binding buffer. Avoid pH extremes (<6.0 or >9.0) and detergent concentrations above 0.1% SDS, which may disrupt the non-inhibitory conformation critical to Maspin's interaction surfaces.

How should I store recombinant Serpin B-5 and what is its shelf life after thawing?

Store at −20°C in single-use aliquots immediately upon receipt. Repeated freeze-thaw cycles accelerate aggregation and should be avoided. Once thawed, keep on ice and use within 8 hours; do not refreeze. Under recommended storage conditions, REC-SerpinB5 is stable for up to 12 months from the date of receipt. If you anticipate frequent use, prepare working aliquots (e.g., 5–10 µg per tube) at the time of first thaw. Purity is >95% by SDS-PAGE and endotoxin is <0.1 EU/µg by LAL assay, so degradation rather than endotoxin contamination is the primary concern to monitor over time.

Can I use recombinant Serpin B-5 as a positive control for Western blot with the RP-SerpinB5 antibody?

Yes — this is one of the most straightforward use cases. Load 50–100 ng of REC-SerpinB5 per lane alongside your cell lysate samples. The matched antibody RP-SerpinB5 (see /anti-serpin-b5-rabbit-polyclonal-antibody) was raised and validated in the same laboratory against the same protein, so band identity at 45–48 kDa is unambiguous. This pairing is particularly useful when validating Maspin expression in tumour tissue lysates where endogenous signal may be low or absent. Because both reagents originate from the same production run and epitope mapping effort, the recombinant serves as a reliable molecular weight marker and signal calibration reference.

How much recombinant Serpin B-5 should I load as a Western blot positive control, and what antibody dilution works?

For a robust positive control signal with RP-SerpinB5, load 50–150 ng of REC-SerpinB5 per lane on a standard 10–12% SDS-PAGE gel. At 50 ng, the band is typically visible with enhanced chemiluminescence at antibody dilutions of 1:1,000–1:2,000. Increasing to 100–150 ng provides a stronger reference band without causing blooming that obscures nearby molecular weight markers. For lysate lanes run in parallel, a total protein load of 20–40 µg from Maspin-expressing lines (MCF-7, 22Rv1) generally produces a comparable signal, aiding side-by-side comparison. Titrate the antibody to your specific ECL substrate and exposure conditions.

Which isoform or processing form of Serpin B-5 does this recombinant represent — is it full-length Maspin?

REC-SerpinB5 represents the canonical full-length human Serpin B-5 isoform (375 amino acids, UniProt P36952, isoform 1). No signal peptide cleavage or pro-domain processing is annotated for Maspin, so the expressed and purified product corresponds to the predominant cytoplasmic and nuclear form detected in epithelial tissues. Alternative splice isoforms have been described in the literature but are not recapitulated by this construct. If your experimental model involves a specific truncation or post-translational variant, confirm isoform identity against your cell line's transcript data before using this recombinant as a standard.

Validation imagery coming soon

Western blot validation figures for REC-SerpinB5 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →